selegiline has been researched along with Schizophrenia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreazza, AC; Berk, M; Dean, O; Kapczinski, F; Magalhães, PV | 1 |
| Bermanzohn, PC; Bodkin, JA; Cole, JO; Hennen, J; Siris, SG | 1 |
| Berner, MM; Hagen, M; Kriston, L | 1 |
| Fohey, KD; Hieber, R; Nelson, LA | 1 |
| Akhondzadeh, S; Amiri, A; Derakhshan, MK; Ghoreishi, A; Hajiazim, M; Khodaie-Ardakani, MR; Nejatisafa, AA; Noorbala, AA; Raznahan, M | 1 |
| Arató, M; Bagdy, G; Perényi, A | 1 |
| Berry, MD; Juorio, AV; Paterson, IA | 1 |
| Cadet, JL; Gewirtz, GR; Gorman, JM; Sarti, P; Sharif, Z | 1 |
| Amico, ET; Ciraulo, DA; Dreyfuss, DA; Goff, DC; Renshaw, PF; Sarid-Segal, O | 1 |
| Bodkin, JA; Cannon, SE; Cohen, BM; Cole, JO; Salomon, MS; Zornberg, GL | 1 |
| Kuhn, W; Müller, T | 1 |
| Jungerman, T; Klein, E; Rabinowitz, D | 1 |
| Elizur, A; Levin, J; Rabey, JM; Rapoport, A; Schwartz, M; Stein, D; Stier, S | 1 |
| Arató, M; Bela, A; Frecska, E; Goswami, U; Perenyi, A | 1 |
| Hietala, J; Koulu, M; Scheinin, M; Syvälahti, E | 1 |
5 review(s) available for selegiline and Schizophrenia
| Article | Year |
|---|---|
Antioxidant treatments for schizophrenia.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Antipsychotic Agents; Ascorbic Acid; Dehydroepiandrosterone; Drug Therapy, Combination; Free Radical Scavengers; Ginkgo biloba; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Schizophrenia; Selegiline; Vitamin E; Vitamins | 2016 |
A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
Topics: Antipsychotic Agents; Erectile Dysfunction; Female; Humans; Male; Monoamine Oxidase Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Research; Research Design; Schizophrenia; Selegiline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Treatment Outcome | 2006 |
The role of selegiline in the treatment of negative symptoms associated with schizophrenia.
Topics: Dopamine Agents; Humans; Monoamine Oxidase Inhibitors; Schizophrenia; Selegiline | 2007 |
Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders.
Topics: Aging; Alzheimer Disease; Animals; Cognition Disorders; Depressive Disorder; Humans; Longevity; Mental Disorders; Monoamine Oxidase Inhibitors; Nervous System Diseases; Parkinson Disease; Schizophrenia; Selegiline | 1994 |
The clinical potential of Deprenyl in neurologic and psychiatric disorders.
Topics: Adult; Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Antipsychotic Agents; Child; Clinical Trials as Topic; Cross-Over Studies; Depression; Double-Blind Method; Humans; Mental Disorders; Middle Aged; Monoamine Oxidase Inhibitors; Narcolepsy; Nervous System Diseases; Neuroprotective Agents; Nootropic Agents; Parkinson Disease, Secondary; Schizophrenia; Selegiline; Supranuclear Palsy, Progressive; Tourette Syndrome; Treatment Outcome | 1996 |
6 trial(s) available for selegiline and Schizophrenia
| Article | Year |
|---|---|
Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
Topics: Administration, Oral; Adult; Ambulatory Care; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Monoamine Oxidase Inhibitors; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selegiline; Treatment Outcome | 2005 |
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Monoamine Oxidase Inhibitors; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Selegiline; Treatment Outcome | 2008 |
A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Free Radicals; Humans; Lipid Peroxidation; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selegiline | 1993 |
Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Selegiline; Severity of Illness Index | 1996 |
Deprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Placebo Effect; Schizophrenia; Selegiline | 1999 |
A trial of L-deprenyl for the treatment of neuroleptic-induced parkinsonism.
Topics: Adult; Analysis of Variance; Antiparkinson Agents; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinsonian Disorders; Psychiatric Status Rating Scales; Regression Analysis; Schizophrenia; Selegiline | 1999 |
4 other study(ies) available for selegiline and Schizophrenia
| Article | Year |
|---|---|
An early phase II trial with L-deprenyl for the treatment of neuroleptic-induced parkinsonism.
Topics: Adult; Antipsychotic Agents; Drug Evaluation; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease, Secondary; Phenethylamines; Prolactin; Schizophrenia; Selegiline | 1983 |
Selegiline for neuroleptic-induced parkinsonism.
Topics: Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Schizophrenia; Selegiline | 1993 |
L-deprenyl in treating negative symptoms of schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selegiline | 1992 |
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Topics: Apomorphine; Bromocriptine; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Metoclopramide; Monitoring, Physiologic; Neurosecretory Systems; Prolactin; Receptors, Dopamine; Schizophrenia; Selegiline; Time Factors | 1985 |